Secondary |
Drug Use For Unknown Indication |
33.3% |
Hypertension |
26.1% |
Trigeminal Neuralgia |
8.7% |
Depression |
5.8% |
Angina Pectoris |
4.3% |
Hyperlipidaemia |
4.3% |
Insomnia |
4.3% |
Prophylaxis |
4.3% |
Arthritis |
1.4% |
Blood Cholesterol Increased |
1.4% |
Facial Neuralgia |
1.4% |
Grand Mal Convulsion |
1.4% |
Hypothyroidism |
1.4% |
Reflux Oesophagitis |
1.4% |
|
Completed Suicide |
29.4% |
Ventricular Hypertrophy |
23.5% |
Hypernatraemia |
5.9% |
Hyponatraemia |
5.9% |
Hypophosphataemia |
5.9% |
Loss Of Consciousness |
5.9% |
Poisoning |
5.9% |
Poisoning Deliberate |
5.9% |
Pruritus |
5.9% |
Somnolence |
5.9% |
|
Concomitant |
Atrial Fibrillation |
26.0% |
Hypertension |
19.1% |
Product Used For Unknown Indication |
9.9% |
Diffuse Large B-cell Lymphoma |
4.6% |
Hepatic Neoplasm Malignant |
4.6% |
Type 2 Diabetes Mellitus |
4.2% |
Aortic Surgery |
3.8% |
Congestive Cardiomyopathy |
3.8% |
Prophylaxis |
3.1% |
Cardiac Failure |
2.7% |
Ovarian Cancer |
2.7% |
Ovarian Epithelial Cancer Recurrent |
2.7% |
Heart Rate |
2.3% |
Thrombosis Prophylaxis |
1.9% |
Diabetes Mellitus |
1.5% |
Drug Use For Unknown Indication |
1.5% |
Irritable Bowel Syndrome |
1.5% |
Sinusitis |
1.5% |
Thrombosis |
1.5% |
Convulsion |
1.1% |
|
Cardiac Failure |
27.0% |
Angina Unstable |
9.5% |
Ischaemic Stroke |
6.8% |
Nausea |
5.4% |
Transient Ischaemic Attack |
5.4% |
Dizziness |
4.1% |
Drug Rash With Eosinophilia And Systemic Symptoms |
4.1% |
Renal Failure Chronic |
4.1% |
Weight Increased |
4.1% |
Blood Pressure Systolic Increased |
2.7% |
Bradyarrhythmia |
2.7% |
C-reactive Protein Increased |
2.7% |
Cardiac Death |
2.7% |
Dry Eye |
2.7% |
Frequent Bowel Movements |
2.7% |
Gastrointestinal Ulcer Haemorrhage |
2.7% |
Hyperkalaemia |
2.7% |
Hypertension |
2.7% |
Hyperthyroidism |
2.7% |
Microalbuminuria |
2.7% |
|
Interacting |
Hypertension |
36.4% |
Trigeminal Neuralgia |
18.2% |
Angina Pectoris |
9.1% |
Depression |
9.1% |
Hyperlipidaemia |
9.1% |
Insomnia |
9.1% |
Prophylaxis |
9.1% |
|
Left Ventricular Hypertrophy |
100.0% |
|